California, Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, today announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers. The new entity named “Crown Bioscience & MBL”, is a long-term strategic partnership that is expected to accelerate growth for both companies. The initial focus is to provide preclinical and translational services to expand Crown Bioscience’s offerings in Japan. The agreement will enhance Crown Bioscience’s current distributor model and establish a local presence to ensure premium service delivery in Japan. Based in Tokyo, Crown Bioscience & MBL will establish a
The post Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers appeared first on Pharma Mirror Magazine.
